Model DetailsIntestine - Large Intestine - Colon foci - aberrant crypt (ACF)
Model Name |
Intestine - Large Intestine - Colon foci - aberrant crypt (ACF) | Strain |
C57BL/6J-ApcMin/+ |
Tumor Inducing Agent(s) |
Chemical/Drug : 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) |
Tumor Synonym |
colonic dysplastic aberrent crypt foci (ACF) |
Strain Synonyms |
C57BL/6J-APCMin/+ • C57BL/6J-ApcMin/J • APCmin/+ • C57BL/6J/Min/+ • C57BL/6J-ApcMin • ApcMin • C57BL/6 ApcMin/+ • C57BL/6J-Min • B6-ApcMin/Apc+ • C57Bl/6J-Min+ • ApcMin • C57BL/6J-ApcMin/+ • Min C57BL/6J • C57BL/6J-APCmin/+ • C57BL/6J Min /+ • ApcMin/+ • Apc+/- • Apc+/- Msh2+/+ • APCMin/+ • Min • C57BL/6J ApcMin/+ • C57Bl/6-Min • adenomatous polyposis coliMin/+ • C57BL/6J-Min/+ • APCMin/+ • C57BL/6J-ApcMin • C57BL/6J-ApcMin/+ • C57BL/6J APCMin/+ • C57BL/6J Min • B6-ApcMin • C57Bl/6-Min/+ • C57BL/6-Min • C57BL/6J-Min/+ • ApcMin/+ • C57BL/6-Min • ApcMin/+ • C57BL/6J-APCMin/+ • C57Bl/6J-Min/+ • Min/+ • ApcMin • ApcMin heterozygous • Min/+ • ApcMin • C57BL/6J-ApcMin/+ • C57Bl/6JMin/+ • Apcmin • multiple intestinal neoplasia • C57BL/6J ApcMin/+ • ApcMin/Apc+ • C57BL/6J Min/+ • B6 Min/+ • Min • C57BL/6J Min • APCMin/+ • C57BL/6J-ApcMin/J • Min/+ C57BL/6J • ApcMin/+ • APCMin/+ • C57BL/6J Apcmin • C57BL/6J/-ApcMin |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Intestine - Large Intestine - Colon | Mixed Population |
93% (14 of 15 mice) |
7 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
67% (10 of 15 mice) |
7 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
50% (8 of 16 mice) |
11 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
58% (7 of 12 mice) |
11 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
59% (13 of 22 mice) |
11 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
82% (9 of 11 mice) |
11 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
observed |
11 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
observed |
11 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
observed |
11 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |
| Intestine - Large Intestine - Colon | Mixed Population |
observed |
11 weeks |
|
Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96 |